Clinical Trials ArenaOriginal article
Alkermes reports positive top-line Phase Ib trial data for ALKS 7290
Phase 1positiveALKS 7290Positive
AI Analysis
Summary
Alkermes reported positive top-line results from a Phase Ib proof-of-concept trial of ALKS 7290 for adults with ADHD.
Clinical Trial Data
Phase
Ib
Primary Endpoint
Met
Outcome Details
Positive top-line findings from Phase Ib proof-of-concept study
Importance:5/10
Sentiment:
0.75
Phase IbADHDproof-of-conceptpositive data
Read the original article
Published by Clinical Trials Arena on September 22, 2026 8:54 AM